Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis

Ahmed Alhusban(University of Georgia), Payaningal R. Somanath(Kent State University)
Journal of Pharmacology and Experimental Therapeutics
July 3, 2014
Cited by 37


Related Papers